Cas 344292-74-6,10-Butyl-3-mesityl-2,5-dimethyl-7,8,9,10-tetrahydro-6H-pyrazolo[5',1'-:2,3]pyrimido[4,5-b]azepine

344292-74-6

Post Buying Request

Basic information

Product Name: 10-Butyl-3-mesityl-2,5-dimethyl-7,8,9,10-tetrahydro-6H-pyrazolo[5',1'-:2,3]pyrimido[4,5-b]azepine
Synonyms: 10-Butyl-3-mesityl-2,5-dimethyl-7,8,9,10-tetrahydro-6H-pyrazolo[5',1'-:2,3]pyrimido[4,5-b]azepine
CAS NO:344292-74-6
Molecular Formula:
Molecular Weight: 390.572
EINECS: N/A
Product Categories: N/A
Mol File: 344292-74-6.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 10-Butyl-3-mesityl-2,5-dimethyl-7,8,9,10-tetrahydro-6H-pyrazolo[5',1'-:2,3]pyrimido[4,5-b]azepine(CAS DataBase Reference)
NIST Chemistry Reference: 10-Butyl-3-mesityl-2,5-dimethyl-7,8,9,10-tetrahydro-6H-pyrazolo[5',1'-:2,3]pyrimido[4,5-b]azepine(344292-74-6)
EPA Substance Registry System: 10-Butyl-3-mesityl-2,5-dimethyl-7,8,9,10-tetrahydro-6H-pyrazolo[5',1'-:2,3]pyrimido[4,5-b]azepine(344292-74-6)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 344292-74-6(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

344292-74-6 Suppliers

Recommended suppliersmore

344292-74-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 344292-74-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,4,2,9 and 2 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 344292-74:
(8*3)+(7*4)+(6*4)+(5*2)+(4*9)+(3*2)+(2*7)+(1*4)=146
146 % 10 = 6
So 344292-74-6 is a valid CAS Registry Number.

344292-74-6Upstream product

7681-82-5 sodium iodide

344292-74-6Downstream Products

344292-74-6Relevant articles and documents

Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same

-

, (2008/06/13)

The present invention provides a novel compound having an excellent corticotrophin-releasing-factor receptor antagonistic activity. That is, it provides a compound represented by the following formula, a pharmacologically acceptable salt thereof or hydrat

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 344292-74-6